🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Molecular Phenotyping of Migraine Patients According to Sex and Age Through CGRP Quantification

Recruitingn/aAges 6 Years - 75 YearsAllHospital Universitari Vall d'Hebron Research Inst…
NCT06674772 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Patients will be asked to visit the study center 2 times, the first time for clinical assessment and a second time for sample collection. Healthy controls will only be asked to visit the study center for sample collection. A sample of blood and saliva will be collected in order to measure CGRP levels and DNA and hormone testing.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Migraine patients according to ICHD-3 criteria * Healthy controls paired to patient age and sex, without headache and without first degree family history of headache. Exclusion Criteria: * Presence of any major medical or neurological illness. * Presence of any salivary gland malfunction. * Abuse or dependence to tobacco, alcohol or any drug in the previous 12 months before the enrollment. * Active migraine preventive treatment. * Pregnant or breastfeeding female.
💊

What it tests

  • Saliva test
📍

Where

1 site
Vall d'Hebron University Hospital
Barcelona, Spain
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy